Skip to main content

Loteprednol etabonate and Tobramycin

NDC 62332-801 · Alembic Pharmaceuticals Inc.

Generic nameLoteprednol etabonate and Tobramycin
Dosage formSUSPENSION/ DROPS
RouteOPHTHALMIC
Active ingredient(s)LOTEPREDNOL ETABONATE, TOBRAMYCIN
Strength5; 3 mg/mL; mg/mL
Pharmacologic classAminoglycoside Antibacterial [EPC], Aminoglycosides [CS], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
Marketing categoryANDA

Packages

62332-801-05 — 1 BOTTLE in 1 CARTON (62332-801-05) / 5 mL in 1 BOTTLE

62332-801-10 — 1 BOTTLE in 1 CARTON (62332-801-10) / 10 mL in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60219-1362 — loteprednol etabonate, 60219-1366 — loteprednol etabonate, 60219-1367 — loteprednol etabonate, 60687-731 — Tobramycin, 60760-583 — Tobramycin, 61314-643 — Tobramycin, 61314-647 — Tobramycin and Dexamethasone, 61919-642 — TOBRAMYCIN, 62250-110 — Tobramycin, 62332-518 — Tobramycin Ophthalmic Solution, 62756-232 — Loteprednol Etabonate, 63187-024 — Tobramycin, 63187-902 — Tobramycin, 63187-973 — Tobramycin, 63629-9570 — tobramycin and dexamethasone, 63629-9571 — tobramycin and dexamethasone, 63629-9572 — tobramycin and dexamethasone, 65162-914 — Tobramycin, 66267-936 — Tobramycin, 66993-195 — tobramycin inhalation, +85 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels